Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
BETA v.3.0

2025 ICD-10-CM code Q85.01

Neurofibromatosis, type 1 (von Recklinghausen's disease).

Code Q85.01 should be used to report a confirmed diagnosis of Neurofibromatosis, type 1 (von Recklinghausen's disease).Do not use this code for suspected cases without confirmatory genetic testing or clear clinical diagnosis.

Medical necessity for NF1 care is established by the presence of characteristic clinical features or a positive genetic test result.Ongoing monitoring and management of complications, such as optic gliomas or neurofibromas, are medically necessary to prevent or address potential morbidity.

Diagnosis and management of NF1 typically involves a multidisciplinary team, including geneticists, neurologists, dermatologists, ophthalmologists, and other specialists as needed.Clinical responsibility includes genetic testing to confirm the diagnosis, regular monitoring for disease progression, and symptomatic management of complications like seizures, learning difficulties, or pain.

In simple words: Neurofibromatosis type 1, also known as von Recklinghausen's disease, is a genetic condition where tumors grow along nerves. It can also cause changes in skin color and sometimes problems with the eyes, bones, and brain. Some people with NF1 have mild symptoms, while others have more serious problems.

Neurofibromatosis, type 1, also known as von Recklinghausen's disease, is an autosomal dominant genetic disorder affecting the nervous system, muscles, bones, and skin. It is characterized by the growth of tumors along nerves, as well as café-au-lait spots (hyperpigmented skin lesions) and Lisch nodules (iris hamartomas). Individuals with NF1 may experience a range of symptoms, from mild skin changes to severe neurological complications like optic nerve gliomas and neurofibrosarcomas.There is also an increased risk of learning disabilities.

Example 1: A pediatrician notices multiple café-au-lait spots on a 6-month-old infant during a well-child visit. Upon further examination, the pediatrician also finds Lisch nodules in the infant’s eyes, raising suspicion for NF1. Genetic testing is ordered to confirm the diagnosis., A 30-year-old adult presents with several soft lumps under their skin and reports a family history of NF1.They undergo a clinical evaluation and genetic testing, which confirms a diagnosis of NF1. They are advised on regular monitoring for potential complications., A child with a known diagnosis of NF1 develops optic glioma, requiring referral to a neuro-ophthalmologist for specialized care and treatment planning.

Documentation for NF1 should include detailed clinical findings, such as the number and size of café-au-lait spots, the presence of neurofibromas or Lisch nodules, any neurological symptoms, and family history. Genetic testing results should also be documented.Records of ongoing monitoring and management of complications should also be maintained.

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.

Discover what matters.

iFrame™ AI's knowledge is aligned with and limited to the materials uploaded by users and should not be interpreted as medical, legal, or any other form of advice by iFrame™.